Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export

Vohhodina, J., Barros, E.M., Savage, A.L.ORCID: 0000-0002-2231-9800, Liberante, F.G., Manti, L., Bankhead, P., Cosgrove, N., Madden, A.F., Harkin, D.P. and Savage, K.I. (2017) The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export. Nucleic Acids Research, 45 (22). pp. 12816-12833.

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (7MB) | Preview
Free to read: https://doi.org/10.1093/nar/gkx1046
*No subscription required

Abstract

mRNA splicing and export plays a key role in the regulation of gene expression, with recent evidence suggesting an additional layer of regulation of gene expression and cellular function through the selective splicing and export of genes within specific pathways. Here we describe a role for the RNA processing factors THRAP3 and BCLAF1 in the regulation of the cellular DNA damage response (DDR) pathway, a key pathway involved in the maintenance of genomic stability and the prevention of oncogenic transformation. We show that loss of THRAP3 and/or BCLAF1 leads to sensitivity to DNA damaging agents, defective DNA repair and genomic instability. Additionally, we demonstrate that this phenotype can be at least partially explained by the role of THRAP3 and BCLAF1 in the selective mRNA splicing and export of transcripts encoding key DDR proteins, including the ATM kinase. Moreover, we show that cancer associated mutations within THRAP3 result in deregulated processing of THRAP3/BCLAF1-regulated transcripts and consequently defective DNA repair. Taken together, these results suggest that THRAP3 and BCLAF1 mutant tumors may be promising targets for DNA damaging chemotherapy.

Item Type: Journal Article
Publisher: Oxford University Press
Copyright: © The Author(s) 2017
URI: http://researchrepository.murdoch.edu.au/id/eprint/61933
Item Control Page Item Control Page

Downloads

Downloads per month over past year